Solventum SOLV Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.26B-0.6% | $8.33B+0.9% | $8.4B+2.3% | $8.39B+2.2% | $8.31B+1.3% | ||
| $4.43B-2.2% | $4.45B-3.1% | $4.54B-1.9% | $4.57B-2.2% | $4.54B-4.1% | ||
| 53.7%-0.9pp | 53.5%-2.2pp | 54.1%-2.3pp | 54.5%-2.5pp | 54.6%-3.1pp | ||
| $736M-4.8% | $740M-4.5% | $764M-0.3% | $770M+1.7% | $773M+2.0% | ||
| $3.14B+6.2% | $3.08B+10.7% | $3.11B+18.7% | $3.03B+24.0% | $2.96B+27.5% | ||
| $2.11B+161% | $2.18B+110% | $2.19B+67.8% | $777M-49.4% | $807M-52.8% | ||
| 25.5%+15.8pp | 26.2%+13.6pp | 26.1%+10.2pp | 9.3%-9.4pp | 9.7%-11.1pp | ||
| -$305M+29.4% | -$347M+5.4% | -$403M-55.0% | -$421M-175% | -$432M-1,008% | ||
| -$32M+48.4% | -$39M+39.1% | -$40M+36.5% | -$36M+45.5% | -$62M-72.2% | ||
| $1.69B+439% | $1.71B+183% | $1.67B+69.7% | $321M-75.6% | $314M-80.8% | ||
| $264M— | $162M— | —— | —— | —— | ||
| $1.43B+278% | $1.56B+225% | $1.52B+112% | $380M-64.1% | $379M-70.6% | ||
| 17.3%+12.8pp | 18.7%+12.9pp | 18.1%+9.4pp | 4.5%-8.4pp | 4.6%-11.2pp | ||
| $8.15+276% | $8.86+221% | $8.69+109% | $2.17-64.5% | $2.17-70.9% | ||
| $2.6B+92.6% | $2.67B+67.8% | $2.71B+46.7% | $1.31B-37.3% | $1.35B-40.3% | ||
| 31.5%+15.2pp | 32.1%+12.8pp | 32.3%+9.8pp | 15.6%-9.8pp | 16.3%-11.3pp | ||
| $2.11B+161% | $2.18B+110% | $2.19B+67.8% | $777M-49.4% | $807M-52.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Solventum's revenue?
- Solventum (SOLV) generated $8.3B in revenue over the trailing twelve months, down 0.5% year over year.
- Is Solventum profitable?
- Solventum reported $1.4B in net income over the trailing twelve months, a 17.3% net margin.
- What are Solventum's profit margins?
- Gross margin is 53.7% and operating margin is 25.5%, with a 17.3% net margin.
- What is Solventum's earnings per share?
- Solventum's diluted EPS over the trailing twelve months is $8.15.
- Where does Solventum's income statement data come from?
- Every line is extracted from Solventum's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
